Wolves’ Chinese parent signs new medtech deal
A global healthcare company financing innovative medtechs has forged a new partnership with Chinese mega-business, Fosun International, to develop and commercialise new clinical therapies for patients.
Hong Kong-listed Fosun, which is conservatively estimated to have total assets of around £53.5bn (c.US$75 billion), is the parent of Championship football club, Wolverhampton Wanderers.
Its new agreement with Arix Bioscience will see the partners collaborate on investments which create new companies focused on the development of ... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
